Suppr超能文献

肠切除术后肠系膜缺血患者的即刻术后肠外抗凝治疗:单中心回顾性队列研究。

Immediate postoperative parenteral anticoagulant therapy in patients with mesenteric ischemia after intestinal resection: a retrospective cohort study at a single institute.

机构信息

Department of Surgery, Taichung Veterans General Hospital, 1650 Taiwan Boulevard Sect. 4, Taichung, 40705, Taiwan, ROC.

School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

出版信息

BMC Gastroenterol. 2023 Mar 8;23(1):56. doi: 10.1186/s12876-023-02691-w.

Abstract

BACKGROUND

Bowel gangrene represents a major fatal event in acute mesenteric ischemia. Intestinal resection is inevitable in patients with peritonitis and bowel gangrene. This retrospective study aimed to elucidate the benefit of postoperative parenteral anticoagulation in patients with intestinal resection.

METHODS

Patients with acute mesenteric ischemia and bowel gangrene were recruited retrospectively between January 2007 and December 2019. All patients underwent bowel resection. They were categorized into two groups: patients without immediate parenteral anticoagulant therapy (Group A) and those with immediate parenteral anticoagulant therapy (Group B). Thirty-day mortality and survival were analyzed.

RESULTS

A total of 85 patients were included, with 29 patients in Group A and 56 patients in Group B. Patients in Group B had lower 30-day mortality (16.1%) and a higher 2-year survival rate (45.4%) than patients in Group A (30-day mortality: 51.7%, p = 0.001; 2-year survival rate: 19.0%, p = 0.001). In the 30-day mortality multivariate analysis, patients in Group B had a better outcome (odds ratio = 0.080, 95% confidence interval between 0.011 and 0.605, p = 0.014). Patients in Group B also had a better outcome in the survival multivariate analysis (hazard ratio: 0.435, 95% confidence interval between 0.213 and 0.887, p = 0.022).

CONCLUSIONS

Immediate postoperative parenteral anticoagulant therapy improves prognosis in patients with acute mesenteric ischemia treated by intestinal resection. Trial registration This research was retrospectively approved by the Institutional Review Board (IRB) I&II of Taichung Veterans General Hospital (TCVGH-IRB No.CE21256B) on July 28th, 2021. The informed consent waiver was also approved by IRB I&II of Taichung Veterans General Hospital. The Declaration of Helsinki and ICH-GCP guidelines were followed during this study.

摘要

背景

肠坏疽是急性肠系膜缺血的主要致死事件。腹膜炎和肠坏疽患者不可避免地需要进行肠切除术。本回顾性研究旨在阐明肠切除术后术后肠外抗凝的益处。

方法

2007 年 1 月至 2019 年 12 月间回顾性招募急性肠系膜缺血伴肠坏疽患者。所有患者均接受肠切除术。他们分为两组:无即时肠外抗凝治疗组(A 组)和即时肠外抗凝治疗组(B 组)。分析 30 天死亡率和存活率。

结果

共纳入 85 例患者,A 组 29 例,B 组 56 例。B 组患者 30 天死亡率(16.1%)较低,2 年生存率(45.4%)较高,高于 A 组(30 天死亡率:51.7%,p=0.001;2 年生存率:19.0%,p=0.001)。在 30 天死亡率的多变量分析中,B 组患者的预后较好(优势比=0.080,95%置信区间 0.011 至 0.605,p=0.014)。B 组患者的生存多变量分析也有较好的结果(风险比:0.435,95%置信区间 0.213 至 0.887,p=0.022)。

结论

急性肠系膜缺血患者接受肠切除术后立即进行肠外抗凝治疗可改善预后。

试验注册

本研究于 2021 年 7 月 28 日经台中荣民总医院机构审查委员会(IRB)I&II 批准(TCVGH-IRB 编号 CE21256B)。IRB I&II 还批准了放弃知情同意。本研究遵循赫尔辛基宣言和 ICH-GCP 指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f21/9996985/61976bbef40d/12876_2023_2691_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验